SelectScience
Join Free
Accelerating Science
NewsDrug Discovery & Development

Ingenza announces move to purpose-built facility at Edinburgh Technopole

Ingenza

The new site is still within the Midlothian Science Zone and is now fully operational, marking a significant milestone in the company’s continued growth

26 May 2025

Industry news

Ingenza is a technology-driven contract research, development and manufacturing organization (CRDMO) that specialises in biologics, small molecule pharmaceuticals and sustainably manufactured industrial products. This move follows a strategic review of the company’s long-term development plans, and the bespoke, state-of-the-art, multi-million-pound Moubray Building is designed to more than double Ingenza’s operational footprint.

The expansion will significantly increase capacity across all service areas, strengthening the company’s ability to deliver flexible, scalable solutions to its growing customer base. The innovative design will allow Ingenza to scale up manufacturing to 100 L, paving the way for the production of first-in-human materials.

The senior leadership team at Ingenza

Jaymin Amin, Chief Business Officer of Ingenza, commented, “This is a landmark investment for Ingenza. It will enable us to significantly increase our operational scale, further expand our research and development laboratories, and enhance our bespoke service offerings to better support the growth of our customers. Central to this expansion is our inGenius® platform technology, which is revolutionising drug substance development for investigational new drug (IND)-enabling studies. This exciting move is not only about gaining physical space; it will also act as a catalyst to accelerate innovation and reinforce our position as a trusted partner in bioprocess development for complex drug substances.”

Ingenza’s CEO Ian Fotheringham added: “Our increased automation and computational biology capabilities at Moubray will turbocharge the expansion of our data-driven codABLE® gene design. Having already enhanced predictability, development speed and performance of protein production in E.coli and Bacillus spp., we now anticipate that codABLE® machine learning will shave weeks or even months off the timeline for delivery of optimised recombinant Pichia pastoris and CHO manufacturing hosts.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

IngenzaCompany website

Tags

Automation Supplies / AccessoriesAutomated accessories and consumables make lab processes fast, efficient and reliable. Useful automation accessories include microplate sealers, label printers and reagent reservoirs.MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.CRO ServicesExplore the comprehensive range of services offered by Contract Research Organizations (CROs) to streamline drug development and clinical research. From preclinical studies to regulatory support and clinical trials, CROs provide expert solutions that help pharmaceutical and biotech companies bring products to market faster and more efficiently.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.

Related articles

Ingenza announces move to purpose-built facility at Edinburgh Technopole